NVAX Stock Up 13%, Novavax Early Trial of COVID-19 Vaccine Shows Stellar Immune Response

2020-8-5 18:17

Coinspeaker NVAX Stock Up 13%, Novavax Early Trial of COVID-19 Vaccine Shows Stellar Immune ResponseScientists have Novavax's vaccine results to be impressive and exemplary. If the company gets more leads going ahead, it promises of producing 100 million doses by the start of 2021.

Similar to Notcoin - TapSwap on Solana Airdrops In 2024

origin »

Stellar (XLM) на Currencies.ru

$ 0.1067 (+0.05%)
Объем 24H $44.356m
Изменеия 24h: -0.13 %, 7d: 1.42 %
Cегодня L: $0.1054 - H: $0.1078
Капитализация $3.089b Rank 36
Цена в час новости $ 0.1082 (-1.39%)

novavax vaccine immune nvax shows stellar early

novavax vaccine → Результатов: 3